Filing metadata

Accession number
0001104659-22-091488
Form type
Form 4
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
Aug 15, 2022
Reporting period
Aug 11, 2022
Description
Insider transaction

Explore SEC Filings Hub